Day One Biopharmaceuticals, Inc.

DAWN

DAWN has 2 disclosed filings on Paydirt over the trailing twelve months from 1 corporate insider: 0 purchases and 2 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Feb 17 and filed Feb 18. The most active filer was Jeremy Bender with 5 filings.

Add to watchlist

Filings, ttm

0 buys · 2 sells

Traders, ttm

1 insider

Volume, ttmiDollar value disclosed in the window

$321K

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Feb 17

Filed Feb 18

ADViAverage daily dollar volume

–

not on file

No price series on file for DAWN yet.

Volume by month

Buys $0 Sells $1.7M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

JB Jeremy Bender CHIEF EXECUTIVE OFFICER 5 filings SB Samuel C. Blackman HEAD OF R&D 3 filings

Recent filings

Jeremy BenderSALE CHIEF EXECUTIVE OFFICER $179K
15,459 sh × $11.60
Exec Feb 17
Filed Feb 18 · 5:30 PM ET Jeremy BenderSALE CHIEF EXECUTIVE OFFICER $142K
15,894 sh × $8.91
Exec Nov 17 2025
Filed Nov 18 2025 · 5:30 PM ET Jeremy BenderSALE CHIEF EXECUTIVE OFFICER $109K
16,058 sh × $6.77
Exec Aug 18 2025
Filed Aug 19 2025 · 5:30 PM ET Jeremy BenderSALE CHIEF EXECUTIVE OFFICER $144K
12,048 sh × $11.96
Exec Feb 18 2025
Filed Feb 21 2025 · 5:30 PM ET † Samuel C. BlackmanSALE HEAD OF R&D $399K
30,000 sh × $13.31
Exec Dec 10 2024
Filed Dec 12 2024 · 5:30 PM ET Jeremy BenderSALE CHIEF EXECUTIVE OFFICER $139K
10,554 sh × $13.21
Exec Nov 18 2024
Filed Nov 19 2024 · 5:30 PM ET Samuel C. BlackmanSALE HEAD OF R&D $456K
28,255 sh across 2 lots
Exec Nov 8 2024
Filed Nov 12 2024 · 5:30 PM ET Samuel C. BlackmanSALE HEAD OF R&D $180K
11,245 sh × $16.03
Exec Nov 7 2024
Filed Nov 8 2024 · 5:30 PM ET Samuel C. BlackmanSALE HEAD OF R&D $427K
30,000 sh × $14.22
Exec Sep 10 2024
Filed Sep 12 2024 · 5:30 PM ET